Furth PA - Search Results

1

Genetically engineered ERα-positive breast cancer mouse models.

Dabydeen SA, Furth PA. Dabydeen SA, et al. Among authors: furth pa. Endocr Relat Cancer. 2014 May 6;21(3):R195-208. doi: 10.1530/ERC-13-0512. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24481326 Free PMC article. Review.

2

Loss of Stat5a delays mammary cancer progression in a mouse model.

Ren S, Cai HR, Li M, Furth PA. Ren S, et al. Among authors: furth pa. Oncogene. 2002 Jun 20;21(27):4335-9. doi: 10.1038/sj.onc.1205484. Oncogene. 2002. PMID: 12082622

3

Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers.

Cotarla I, Ren S, Zhang Y, Gehan E, Singh B, Furth PA. Cotarla I, et al. Among authors: furth pa. Int J Cancer. 2004 Feb 20;108(5):665-71. doi: 10.1002/ijc.11619. Int J Cancer. 2004. PMID: 14696092

4

Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.

Jamerson MH, Johnson MD, Korsmeyer SJ, Furth PA, Dickson RB. Jamerson MH, et al. Among authors: furth pa. Br J Cancer. 2004 Oct 4;91(7):1372-9. doi: 10.1038/sj.bjc.6602137. Br J Cancer. 2004. PMID: 15354213 Free PMC article.

5

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

Tilli MT, Reiter R, Oh AS, Henke RT, McDonnell K, Gallicano GI, Furth PA, Riegel AT. Tilli MT, et al. Among authors: furth pa. Mol Endocrinol. 2005 Mar;19(3):644-56. doi: 10.1210/me.2004-0106. Epub 2004 Nov 18. Mol Endocrinol. 2005. PMID: 15550471

6

Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ.

Frech MS, Halama ED, Tilli MT, Singh B, Gunther EJ, Chodosh LA, Flaws JA, Furth PA. Frech MS, et al. Among authors: furth pa. Cancer Res. 2005 Feb 1;65(3):681-5. Cancer Res. 2005. PMID: 15705859 Free PMC article.

7

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.

Jones LP, Li M, Halama ED, Ma Y, Lubet R, Grubbs CJ, Deng CX, Rosen EM, Furth PA. Jones LP, et al. Among authors: furth pa. Oncogene. 2005 May 19;24(22):3554-62. doi: 10.1038/sj.onc.1208426. Oncogene. 2005. PMID: 15750629

8

The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM. Ma Y, et al. Among authors: furth pa. Mol Endocrinol. 2006 Jan;20(1):14-34. doi: 10.1210/me.2004-0488. Epub 2005 Aug 18. Mol Endocrinol. 2006. PMID: 16109739 Free PMC article.

9

Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer.

Parrish A, Halama E, Tilli MT, Freedman M, Furth PA. Parrish A, et al. Among authors: furth pa. J Biomed Opt. 2005 Sep-Oct;10(5):051602. doi: 10.1117/1.2065827. J Biomed Opt. 2005. PMID: 16292950 Free article.

10

Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer.

Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA. Jones LP, et al. Among authors: furth pa. Oncogene. 2008 Jan 31;27(6):794-802. doi: 10.1038/sj.onc.1210674. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters